InterferonsInterferon Type IInterferon InducersInterferon-alphaReceptors, InterferonInterferon-gammaInterferon-betaInterferon Regulatory Factor-3Interferon Regulatory Factor-1Interferon Regulatory FactorsReceptor, Interferon alpha-betaInterferon Regulatory Factor-7Antiviral AgentsRecombinant ProteinsTreatment OutcomePoly I-CInterferon Regulatory Factor-2Newcastle disease virusRibavirinCell LineDrug Therapy, CombinationVesicular stomatitis Indiana virusSTAT1 Transcription Factor2',5'-Oligoadenylate SynthetasePolyethylene GlycolsL Cells (Cell Line)Hepatitis C, ChronicCells, CulturedCytokinesMice, Inbred C57BLVirus ReplicationMice, Inbred BALB CTime FactorsEncephalomyocarditis virusDose-Response Relationship, DrugSTAT2 Transcription FactorDouble-Blind MethodImmunity, InnateHepacivirusInterferon-Stimulated Gene Factor 3RNA, MessengerDrug Administration ScheduleSignal TransductionInterferon-Stimulated Gene Factor 3, gamma SubunitMyxovirus Resistance ProteinsGene Expression RegulationMacrophagesSpleenDisease Models, AnimalT-LymphocytesMolecular Sequence DataTumor Necrosis Factor-alphaHepatitis CAntineoplastic AgentsRNA, Double-StrandedFibroblastsParainfluenza Virus 1, HumanRNA, ViralMice, KnockoutKiller Cells, NaturalViral InterferenceLeukocytes, MononuclearInterleukin-12Antibodies, MonoclonalVirus DiseasesBase SequenceDNA-Binding ProteinsInjections, SubcutaneousDendritic CellsDrug SynergismLeukocytesLymphocyte ActivationAdministration, OralSendai virusInterleukin-4CD4-Positive T-LymphocytesProspective StudiesLymphocytesAdjuvants, ImmunologicViral Nonstructural ProteinsCell Line, TumorInterleukin-2Transcription, GeneticImmunologic FactorsCytopathogenic Effect, ViralDrug CombinationsViral ProteinsDEAD-box RNA HelicasesCD8-Positive T-LymphocytesGene ExpressionViral LoadFollow-Up StudiesInterleukinsFlow CytometryRecurrenceTiloroneRandomized Controlled Trials as TopiceIF-2 KinaseTumor Cells, CulturedChemokine CXCL10